Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence;Zvýšená aktivita sympatiku a možnosti terapeutického ovlivnění

Vnitrni Lekarstvi

Volumn 53, Issue 5, 2007, Pages 554-559

  Souček, Miroslav ^a   Nevrlka, J ^a   Rihacek I ^a   Frana P ^a   Plachy M ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Autonomic nervous system; Chronic stress; Essential hypertension; Heart rate; Treatment

Indexed keywords

ACEBUTOLOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; BOPINDOLOL; CARVEDILOL; CELIPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAZOLIDINE DERIVATIVE; METIPRANOLOL; METOPROLOL; NEBIVOLOL; PINDOLOL; SOTALOL; VERAPAMIL; ANTIHYPERTENSIVE AGENT;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC STRESS; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; MUSCLE HYPERTONIA; PATHOPHYSIOLOGY; REST; DRUG EFFECT; HYPERTENSION; PHYSIOLOGY; REVIEW; STRESS;

ANTIHYPERTENSIVE AGENTS; HEART RATE; HUMANS; HYPERTENSION; STRESS; SYMPATHETIC NERVOUS SYSTEM;

EID: 34250660197     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Kára T, Souček M. Autonomní nervový systém. In: Souček M, Kára T et al. Klinická patofyziologie hypertenze. Praha: Grada Publishing, 2002: 37-100.
2. Pickering TG. The effects of enviromental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous systém. J Hum Hypertens 1997; 11 (Suppl 1): S9-S18.
3. Fišer B. Škodlivý účinek zvýšené sympatické aktivity u arteriá lní hypertenze. Cor Vasa 1999; 41: 241-246.
4. Rosolová H. Úloha sympatické nervové aktivity u esenciální arteriální hypertenze. Cor Vasa 1998; 40: 273-275.
5. Palatini P, Casiglia E, Pauletto P et al. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with micture analysis in three populations. Hypertension 1997; 30: 1267-1273.
6. Julius S Interaction between renin and the autonomic nervous system in hypertension. Am Heart J 1988; 116: 611-616.
7. Julius S, Majahalme S. The changing face of sympathetic overactivity in hypertension. Ann Med 2000; 6: 365-370.
8. Palatini P, Julius S. Heart rate and the cardiovascular rise. J Hypertens 1997; 15: 1-15.
9. Gillman MW, Kannel WB, Belanger A et al. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993; 125: 1148-1154.
10. Morcet JF, Safar M, Thomas F et al. Associations between heart rate and other risk factors in a large French population. J Hypertens 1999; 17: 1671-1676.
11. Levy RL, Hillman CC, Stroud WD et al. Transient hypertension: its significance in terms of later development of sustained hypertension and cardiovascular-renal diseases. JAMA 1944; 126: 829-833.
12. Widimsky J, Fejfarova MH, Fejfar Z. Changes of cardiac output in hypertensive disease. Cardiologia 1957; 31: 381-389.
13. Zuanetti G, Mantini L, Hernández-Bernal F. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insight from the GISSI-2 study. Eur Heart J 1998; (Suppl F): 19-26.
14. Julius S. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension. Eur Heart J 1998; 19 (Suppl F): 14-18.
15. Palatini P, Julius S Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997; 11 (Suppl. 1): S19-S27.
16. Mangoni AA, Mircoli L, Giannattasio C et al. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996; 14: 897-901.
17. Kaplan J, Manuck SB, Clarkson TB. The influence of heart rate on coronary artery atheroslerosis. J Cardiovasc Pharmacol 1987; 10 (2 Suppl): S100-S102.
18. Schmidt-Nielsen K Animal physiology: adaptation and enviroment. New York: Cambridge University Press, 1975: 133.
19. Nishime EO, Cole CR, Blackstone EH et al. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 2000; 284: 1392-1398.
20. Placheta Z, Sieglová J, Štejfa M et al. Zátěžová diagnostika v ambulantní a klinické praxi. Praha: Grada Publishing, 1999.
21. Cífková R, Horký K, Widimský J st et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2004. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2004; 50: 709-722.
22. Prevence kardiovaskulárních onemocnění v dospělém věku - Společné doporuč ení českých odborných společností. Vnitř Lék 2005; 51: 3-15.
23. Widimský J Betablokátory. In: Souček M, Kára T et al. Klinická patofyziologie hypertenze. Praha: Grada Publishing, 2002: 572-580.
24. Janoušek S. Beta-blokátory v klinické praxi. Causa Subita 2003; 6: 461-465.
25. Vítovec J, Špinar J. Farmakoterapie kardiovaskulá rních onemocnění. 2. ed. Praha: Grada Publishing 2004: 53-68.
26. Benetos A, Rudnichi A, Thomas F et al. HTA - fréquence cardiaque et risque cardiovasculaire. Arch Mai Coeur Vaiss 1993; (Suppl 11): 1371-1376.